1-Benzyl 4-(tert-butyl) (S)-2-(cyanomethyl)piperazine-1,4-dicarboxylate, 97%, 100mg

4-Methyl-1H-pyrazol-3-amine, 95.0%, 5g

4H-Pyrimido[2,1-a]isoquinolin-4-one, 2-(4-morpholinyl)-, 98%, 10mg

N-(4-Hydroxyphenethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 98%, 1g

3-Phenoxybutan-2-one, 97%, 5g

3-METHYL-1H-INDAZOL-6-AMINE, 95%, 5g

Dibenzo[b,d]furan-2-ylboronic acid, 95.0%, 1g

H-Val-NH2.HCl, 95%, 1g

4-Fluoro-4'-(trans-4-propylcyclohexyl)-1,1'-biphenyl, 95.0%, 10g

2,1,3-Benzothiadiazole-4,5-diamine, 98%, 100mg

N,N-Diethyl-1,3-propanediamine Dihydrochloride>98.0%(T)5g

2-Methylthieno[3,2-d]pyrimidin-4-ol, 95.0%, 5g

GC capillary column ROTI®Cap-5, 25 m, 0.32 mm, 0.25 µm, 1 Piece(s)